| 國立成功大學 |
2018-4-27 |
Bortezomib enhances radiosensitivity in oral cancer through inducing autophagy-mediated TRAF6 oncoprotein degradation (代表著作1)
|
吳沅樺; WU, YUAN HUA; Wu, Yuan-Hua;Wu, Wun-Syuan;Lin, Li-Ching;Liu, Chiang-Shin;Ho, Sheng-Yow;Wang, Bour-Jr;Huang, Bu-Miin;Yeh, Ya-Ling;Chiu, Hui-Wen;Yang, Wei-Lei;Wang, Ying-Jan |
| 中國醫藥大學 |
2006-12 |
Bortezomib in refractory diffuse large b cell lymphoma; a case report
|
謝清昀(Ching-Yun Hsieh); 葉士芃(Shih-Peng Yeh); 白禮源(Li-Yuan Bai); 林振源(Chen-Yuan Lin); 黃馨慧(Hsin-Hui Huang); 廖裕民(Yu-Min Liao); 邱昌芳(Chang-Fang Chiu) |
| 國立成功大學 |
2020-01 |
Bortezomib induces HSV-1 lethality in mice with neutrophil deficiency
|
Yao;Hui-Wen;Wang;Li-Chiu;Tsai;Hsien-Yang;Fang;Yi-Hsuan;Zheng;Chunfu;Chen;Shun-Hua;Hsu;Sheng-Min |
| 國立成功大學 |
2020-01-01 |
Bortezomib induces HSV-1 lethality in mice with neutrophil deficiency
|
許聖民; Hsu, Sheng-Min; Yao, Hui-Wen, Wang, Li-Chiu;Tsai, Hsien-Yang;Fang, Yi-Hsuan;Zheng, Chunfu;Chen, Shun-Hua |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Trail Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of P13k/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國家衛生研究院 |
2009-04-24 |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen, KF;Yeh, PY;Hsu, C;Hsu, CH;Lu, YS;Hsieh, HP;Chen, PJ;Cheng, AL |
| 臺大學術典藏 |
2022-08-19T00:21:05Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; CHIUN HSU; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; Cheng A.-L. |
| 國立臺灣大學 |
2009 |
Bortezomib Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway
|
陳昆鋒; 葉培彥; 許駿; 徐志宏; 盧彥伸; 謝興邦; 陳培哲; 鄭安理; CHEN, KUEN-FENG; YEH, PEI-YEN; HSU, CHIUN; HSU, CHIH-HUNG; LU, YEN-SHEN; HSIEH, HSING-PANG; CHEN, PEI-JER; CHENG, ANN-LII |
| 臺大學術典藏 |
2020-04-10T12:51:21Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; Chiun Hsu; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:04Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen P.-J; Cheng A.-L.; Hsieh H.-P; YEN-SHEN LU; Hsu C.-H; Hsu C; Yeh P.-Y; Cheng A.-L.;Chen P.-J;Hsieh H.-P;Yen-Shen Lu;Hsu C.-H;Hsu C;Yeh P.-Y;Chen K.-F; Chen K.-F |
| 臺大學術典藏 |
2021-07-03T03:34:50Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:54:22Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:05Z |
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A
|
Chen, K.-F. Yu, H.-C. Liu, C.-Y. Chen, H.-J. Chen, Y.-C. Hou, D.-R. Chen, P.-J. Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2021-07-03T03:34:38Z |
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A
|
Chen K.-F.; Yu H.-C.; Liu C.-Y.; Chen H.-J.; Chen Y.-C.; Hou D.-R.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:54:10Z |
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A
|
Chen K.-F.; Yu H.-C.; Liu C.-Y.; Chen H.-J.; Chen Y.-C.; Hou D.-R.; Chen P.-J.; ANN-LII CHENG |
| 國家衛生研究院 |
2010-01-30 |
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B
|
Ko, BS;Chang, TC;Chen, CH;Liu, CC;Kuo, CC;Hsu, C;Shen, YC;Shen, TL;Golubovskaya, VM;Chang, CC;Shyue, SK;Liou, JY |
| 臺大學術典藏 |
2022-08-19T00:21:04Z |
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B
|
Liou J.-Y.; Shyue S.-K.; Chang C.-C.; Golubovskaya V.M.; Shen T.-L.; Shen Y.-C.; CHIUN HSU; Kuo C.-C.; Ko B.-S.; Chang T.-C.; Chen C.-H.; Liu C.-C. |
| 國立臺灣大學 |
2010-12 |
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B
|
Ko, Bor-Sheng; Chang, Tzu-Ching; Chen, Chien-Hung; Liu, Chia-Chia; Liang, Shu-Man; Hsing, En-Wei; Kuo, Cheng-Chin; Hsu, Chiun; Shen, Ying-Chun; Shen, Tang-Long; Shyue, Song-Kun; Golubovskaya, Vita M.; Chang, Chung-Che; Liou, Jun-Yang |
| 國立臺灣大學 |
2010 |
Bortezomib Suppresses Focal Adhesion Kinase Expression Via Interrupting Nuclear Factor-Kappa B
|
柯博升; 張孜菁; 陳建宏; 劉佳佳; 郭呈欽; 許駿; 沈盈君; 沈湯龍; 徐松錕; 劉俊揚; KO, BO-SHENG; CHANG, TZU-CHING; CHEN, CHIEN- HUNG; LIU, CHIA-CHIA; KUO, CHENG-CHIN; HSU, CHIUN; SHEN, YING-CHUN; SHEN, TANG-LONG; SHYUE, SONG-KUN; LIOU, JUN-YANG |
| 臺大學術典藏 |
2020-04-10T12:51:20Z |
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B
|
Ko B.-S.;Chang T.-C.;Chen C.-H.;Liu C.-C.;Kuo C.-C.;Chiun Hsu;Shen Y.-C.;Shen T.-L.;Golubovskaya V.M.;Chang C.-C.;Shyue S.-K.;Liou J.-Y.; Ko B.-S.; Chang T.-C.; Chen C.-H.; Liu C.-C.; Kuo C.-C.; Chiun Hsu; Shen Y.-C.; Shen T.-L.; Golubovskaya V.M.; Chang C.-C.; Shyue S.-K.; Liou J.-Y. |
| 臺大學術典藏 |
2021-03-09T05:18:37Z |
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B
|
Ko B.-S.; Chang T.-C.; Chen C.-H.; Liu C.-C.; Kuo C.-C.; Hsu C.; Ying-Chun Shen; Shen T.-L.; Golubovskaya V.M.; Chang C.-C.; Shyue S.-K.; Liou J.-Y. |
| 臺大學術典藏 |
2021-01-12T12:53:47Z |
Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
|
SHANG-YI HUANG; Chen T.-Y.; Kuo C.-Y.; Chen Y.-C.; Lin S.-F.; Chang M.-C.; Lv X.; Yang B.; Chang C.-S. |
| 國立成功大學 |
2019 |
Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
|
Huang, S.-Y.;Chen, T.-Y.;Kuo, C.-Y.;Chen, Y.-C.;Lin, S.-F.;Chang, M.-C.;Lv, X.;Yang, B.;Chang, Chang C.-S. |
| 國立成功大學 |
2022-06-17 |
Bortezomib 在小鼠模型中降低增殖性玻璃體視網膜病變的嚴重性
|
劉思琪; Liu, Szu-Chi |
| 國立成功大學 |
2017-11 |
Bortezomib-induced miRNAs direct epigenetic silencing of locus genes and trigger apoptosis in leukemia
|
Chu;Yu-Yi;Ko;Chiung-Yuan;Wang;Shao-Ming;Lin;Pin-I;Wang;Han-Ying;Lin;Wen-Chi;Wu;Dong-Yu;Wang;Lu-Hao;Wang;Ju-Ming |
